These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1763113)

  • 21. Regulation of central muscarinic receptors after cholinesterase inhibition: effect of clonidine.
    Yang XH; Li W; Erwin L; Buccafusco JJ
    Brain Res Bull; 1993; 32(6):681-4. PubMed ID: 8221166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms.
    Faiman CP; de Erausquin GA; Baratti CM
    Behav Neural Biol; 1991 Sep; 56(2):183-99. PubMed ID: 1759940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of telemetry to record body temperature and activity in mice.
    Clement JG; Mills P; Brockway B
    J Pharmacol Methods; 1989 Apr; 21(2):129-40. PubMed ID: 2716336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The post-training memory enhancement induced by physostigmine and oxotremorine in mice is not state-dependent.
    Baratti CM; Kopf SR
    Neurobiol Learn Mem; 1996 Mar; 65(2):121-4. PubMed ID: 8833101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermic response of selective muscarinic agonists and antagonists in rat.
    Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1991 Feb; 29(2):131-5. PubMed ID: 1869296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation.
    Koda K; Ago Y; Yano K; Nishimura M; Kobayashi H; Fukada A; Takuma K; Matsuda T
    Br J Pharmacol; 2011 Feb; 162(3):763-72. PubMed ID: 20958289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement by nifedipine of cholinergic-induced depression of locomotor activity in mice.
    Sansone M; Battaglia M; Pavone F
    Funct Neurol; 1995; 10(4-5):163-7. PubMed ID: 8749042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
    Wetherell JR
    J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central muscarinic cholinergic influences on ethanol sensitivity in long-sleep and short-sleep mice.
    Erwin VG; Korte A; Jones BC
    J Pharmacol Exp Ther; 1988 Dec; 247(3):857-62. PubMed ID: 3204520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine-like discriminative stimulus effects of acetylcholinesterase inhibitors and a muscarinic receptor agonist in Rhesus monkeys.
    Moerke MJ; McMahon LR
    Drug Dev Ind Pharm; 2019 May; 45(5):861-867. PubMed ID: 30712397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla.
    Gillis RA; Walton DP; Quest JA; Namath IJ; Hamosh P; Dretchen KL
    J Pharmacol Exp Ther; 1988 Nov; 247(2):765-73. PubMed ID: 3183970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral versus central muscarinic effects on blood pressure, cardiac contractility, heart rate, and body temperature in the rat monitored by radiotelemetry.
    Smith EC; Padnos B; Cordon CJ
    Pharmacol Toxicol; 2001 Jul; 89(1):35-42. PubMed ID: 11484908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance to anticholinesterase compounds in mammals.
    Costa LG; Schwab BW; Murphy SD
    Toxicology; 1982; 25(2-3):79-97. PubMed ID: 6760465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
    Bushnell PJ; Kelly KL; Ward TR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):15-25. PubMed ID: 7518512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central muscarinic M2 cholinoceptors involved in cholinergic hypertension.
    Ozkutlu U; Onat F; Aslan AN; Oktay S
    Eur J Pharmacol; 1993 Dec; 250(3):349-54. PubMed ID: 8112394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological evidence for nicotinic and muscarinic modulation of spinal cord reflexes.
    Ibrahim NA; Goldstein BD
    Neuropharmacology; 1989 Sep; 28(9):977-83. PubMed ID: 2812287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Action of organophosphate anticholinesterases on the three conformational states of nicotinic receptor.
    Chi M; Sun M
    Adv Exp Med Biol; 1995; 363():65-73. PubMed ID: 7618531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The characterization of oxotremorine-induced hypothermic response in the rat.
    Ryan PM; Kelly JP; Chambers PL; Leonard BE
    Pharmacol Toxicol; 1996 Nov; 79(5):238-40. PubMed ID: 8936556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats.
    Grauer E; Levy A
    Toxicology; 2007 Dec; 242(1-3):1-6. PubMed ID: 17931764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.